PT. Kimia Farma (Persero) Tbk clinical trials
Acquired by PT Bio Farma, Jan 2020 · source ↗
The registry lists 4 studies whose lead sponsor is PT. Kimia Farma (Persero) Tbk. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 2, 2023.
Before and after it joined PT Bio Farma
- First submitted before PT. Kimia Farma (Persero) Tbk became part of PT Bio Farma
- 0
- First submitted after PT. Kimia Farma (Persero) Tbk became part of PT Bio Farma
- 4
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- PT. Kimia Farma (Persero) Tbk4 studies
Something wrong with this grouping? Tell us on the PT Bio Farma page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All PT Bio Farma studies →
- Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy VolunteersCompletedNCT04982874Not applicable
Sponsor listed in the registry: PT. Kimia Farma (Persero) Tbk · First submitted after PT. Kimia Farma (Persero) Tbk became part of PT Bio Farma
- Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy SubjectCompletedNCT04988646Not applicable
Sponsor listed in the registry: PT. Kimia Farma (Persero) Tbk · First submitted after PT. Kimia Farma (Persero) Tbk became part of PT Bio Farma
- The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated VaccineStatus unknownNCT05126550
Sponsor listed in the registry: PT. Kimia Farma (Persero) Tbk · First submitted after PT. Kimia Farma (Persero) Tbk became part of PT Bio Farma
- Safety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)Status unknownNCT05172193Phase 2
Sponsor listed in the registry: PT. Kimia Farma (Persero) Tbk · First submitted after PT. Kimia Farma (Persero) Tbk became part of PT Bio Farma